Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Change in Receivables (2016 - 2025)

Orthopediatrics has reported Change in Receivables over the past 10 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Change in Receivables at $1.1 million for Q4 2025, up 355.48% from a year ago — trailing twelve months through Dec 2025 was $9.4 million (up 97.22% YoY), and the annual figure for FY2025 was $9.4 million, up 97.22%.
  • Change in Receivables for Q4 2025 was $1.1 million at Orthopediatrics, up from -$3.1 million in the prior quarter.
  • Over the last five years, Change in Receivables for KIDS hit a ceiling of $9.9 million in Q2 2025 and a floor of -$3.2 million in Q4 2023.
  • Median Change in Receivables over the past 5 years was $296500.0 (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Change in Receivables: surged 100200.0% in 2023 and later plummeted 622.86% in 2025.
  • Orthopediatrics' Change in Receivables stood at -$250000.0 in 2021, then crashed by 533.6% to -$1.6 million in 2022, then tumbled by 99.12% to -$3.2 million in 2023, then soared by 86.4% to -$429000.0 in 2024, then soared by 355.48% to $1.1 million in 2025.
  • The last three reported values for Change in Receivables were $1.1 million (Q4 2025), -$3.1 million (Q3 2025), and $9.9 million (Q2 2025) per Business Quant data.